Jun 29, 2026 07:00AM
Jun 29, 2026 07:00AM
Jun 12, 2026 07:00AM
Jun 12, 2026 07:00AM
May 27, 2026 07:00AM
May 6, 2026 07:00AM
May 4, 2026 07:01AM BioCryst licenses navenibart to Neopharmed Gentili for European market
May 4, 2026 07:00AM
Apr 6, 2026 07:00AM
Apr 6, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 11, 2026 07:00AM
Jan 23, 2026 09:00AM
Jan 23, 2026 09:00AM BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema 
Jan 12, 2026 07:04AM
Jan 12, 2026 07:00AM
Dec 12, 2025 07:00AM
Dec 12, 2025 07:00AM
Nov 16, 2025 03:00PM
Nov 12, 2025 08:00AM
Nov 6, 2025 08:00AM BioCryst presents pediatric HAE data at medical conference
Nov 6, 2025 08:00AM
Nov 3, 2025 07:00AM
Oct 23, 2025 07:00AM
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM
Sep 11, 2025 08:18AM
Aug 11, 2025 07:02AM BioCryst chief research officer to depart September 1
Aug 11, 2025 07:00AM
Aug 4, 2025 07:00AM
Jul 31, 2025 07:00AM
Jul 31, 2025 07:00AM
Jul 9, 2025 07:00AM
Jul 7, 2025 07:01AM
Jul 7, 2025 07:00AM BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
Jun 16, 2025 07:02AM
Jun 16, 2025 07:00AM
Jun 13, 2025 07:00AM
Jun 13, 2025 07:00AM
Jun 6, 2025 07:00AM
Jun 6, 2025 07:00AM
Jun 2, 2025 07:00AM BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
May 30, 2025 07:01AM
May 30, 2025 07:00AM
May 16, 2025 07:01AM
May 16, 2025 07:00AM
May 14, 2025 07:00AM
May 6, 2025 09:43AM
May 5, 2025 07:00AM BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update
May 1, 2025 07:02AM

324,696 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All